![PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen](https://www.researchgate.net/profile/Venkateshwaran-Sivaraj/publication/296189753/figure/tbl2/AS:720469598687234@1548784746687/Presenting-conditions-requiring-nutritional-intervention_Q320.jpg)
PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen
![PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen](https://www.researchgate.net/profile/Venkateshwaran-Sivaraj/publication/296189753/figure/tbl5/AS:720469598674955@1548784746796/Time-until-samples-became-TB-culture-ve-as-antituberculous-therapy-ATT-progressed_Q320.jpg)
PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen
![PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen PDF) Clinical outcomes after switching HIV-positive patients with HIV viral load less than 100 copies from a PI-based regimen to a tenofovir, emtricitabine and efavirenz regimen](https://www.researchgate.net/profile/Venkateshwaran-Sivaraj/publication/296189753/figure/tbl4/AS:720469598674952@1548784746731/Comparison-of-INSTI-to-Determine-RTDs-using-164-serum-samples_Q320.jpg)